Skip to main content

Table 2 The p values for the differences in treatment options for patients who died or had a relapse (n = 57) according to their dichotomized density profiles

From: Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer

  VLD vs MID*
Adjuvant chemotherapy 0.398
Herceptin 0.229
Hormonal Therapy 0.419
Radiotherapy 0.762
  1. *VLD very low densiy, MID Mixed density